FIELD: organic chemistry.
SUBSTANCE: invention relates to methods for stabilizing compounds based on benzimidazole or its physiologically acceptable salt. One variant of a method involves incorporation of crospovidone having small diameter of particles and at least one compound taken among sodium hydroxide and potassium hydroxide into benzimidazole-base compound represented by the formula (1):
wherein Het1 means:
Het2 means:
R1 and R2 are similar or different and taken among hydrogen atom, methoxy- and difluoromethoxy-group; R3 is taken among hydrogen and sodium atom; R4, R5 and R6 are similar or different and taken among group comprising hydrogen atom, methyl, methoxy-, methoxypropoxy- and trifluoroethoxy-group, or its physiologically acceptable salt. Other variants involve applying at least one compounds taken among sodium hydroxide and potassium hydroxide on core formed by incorporation of crospovidone into benzimidazole-base compound represented by the formula (1) or its physiologically acceptable salt, enteric soluble coating, or intermediate coating and the following applying additional enteric soluble coating on it. Also, invention relates to a method for prevention of the benzimidazole-base compound color change or its physiologically acceptable salts and this method involves incorporation of crospovidone and at least one compound taken among sodium hydroxide and potassium hydroxide into benzimidazole-base compound by cl. 1, or its physiologically acceptable salt.
EFFECT: improved stabilizing method.
7 cl, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF SUSTAINED-RELEASE PREPARATION FOR RELEASING OF ACID SECRETION INHIBITOR IN STOMACH AND METHOD FOR PRODUCTION THEREOF | 2002 |
|
RU2311906C2 |
PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE AND METHOD OF PRODUCTION THEREOF | 2005 |
|
RU2337687C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
PHARMACEUTICAL COMPOSITION CONTAINING A PROTON PUMP INHIBITOR AND ANTACID | 2020 |
|
RU2807610C1 |
METHOD OF PREPARING BENZIMIDAZOLE DERIVATIVES STABLE IN ACID MEDIUM | 1992 |
|
RU2105773C1 |
ENTERIC COATED PELLETS, METHOD FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM | 2021 |
|
RU2821366C1 |
TABLETTED MULTICOMPONENT MEDICINAL FORM, METHOD OF PREPARATION THEREOF, PACKAGE, AND METHOD FOR INHIBITING GASTRIC ACID SECRETION AND/OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES | 1995 |
|
RU2160094C2 |
TABLETTED MULTIUNIT MEDICINAL FORM, METHOD OF ITS PREPARING, METHOD OF INHIBITION OF GASTRIC ACID SECRETION OR TREATMENT OF MAMMALS AND HUMANS WITH GASTROENTERIC DISEASES | 1995 |
|
RU2166935C2 |
Authors
Dates
2005-09-10—Published
2000-10-19—Filed